D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.41% |
| 2 | Technology | 9.4% |
| 3 | Healthcare | 8.95% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
KRONOS Worldwide
KRO
$705M
| $1.12M | ﹤0.01% |
102,256
-54,330
| -35% | -$681K |
|
2602
Standex International
SXI
$3.75B
| $1.12M | ﹤0.01% |
14,030
+8,430
| +151% | +$686K |
|
2603
Travere Therapeutics
TVTX
$5.27B
| $1.11M | ﹤0.01% |
33,619
-6,081
| -15% | -$167K |
|
|
TNGO
2604
DELISTED
Tangoe, Inc.
TNGO
| $1.11M | ﹤0.01% |
88,525
-493
| -0.6% | -$6.62K |
|
2605
CALL
Generac Holdings
GNRC
$11.6B
| $1.11M | ﹤0.01% |
28,000
| – | – |
|
2606
FTI Consulting
FCN
$4.88B
| $1.11M | ﹤0.01% |
26,930
+11,523
| +75% | +$459K |
|
2607
Hanmi Financial
HAFC
$942M
| $1.11M | ﹤0.01% |
44,681
+15,564
| +53% | +$348K |
|
|
STNR
2608
DELISTED
STEINER LEISURE LTD
STNR
| $1.11M | ﹤0.01% |
20,599
+1,303
| +7% | +$65.7K |
|
|
NAME
2609
DELISTED
Rightside Group, Ltd.
NAME
| $1.11M | ﹤0.01% |
163,650
+1,029
| +0.6% | +$8.64K |
|
2610
KB Financial Group
KB
$41.5B
| $1.11M | ﹤0.01% |
33,668
+15,244
| +83% | +$550K |
|
2611
Curtiss-Wright
CW
$27.5B
| $1.11M | ﹤0.01% |
+15,279
| New | +$1.13M |
|
2612
Westamerica Bancorp
WABC
$1.38B
| $1.1M | ﹤0.01% |
21,763
-6,019
| -22% | -$277K |
|
2613
Abbott
ABT
$182B
| $1.1M | ﹤0.01% |
22,451
-54,946
| -71% | -$2.64M |
|
2614
Landstar System
LSTR
$6.5B
| $1.1M | ﹤0.01% |
16,430
+10,960
| +200% | +$712K |
|
|
DSCI
2615
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $1.1M | ﹤0.01% |
153,172
+90,866
| +146% | +$683K |
|
2616
British American Tobacco
BTI
$131B
| $1.1M | ﹤0.01% |
20,256
+3,694
| +22% | +$204K |
|
2617
CALL
Itaú Unibanco
ITUB
$92.3B
| $1.09M | ﹤0.01% |
249,441
| – | – |
|
|
YDKN
2618
DELISTED
Yadkin Financial Corporation
YDKN
| $1.09M | ﹤0.01% |
52,286
-2,265
| -4% | -$45.7K |
|
|
ARNA
2619
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.09M | ﹤0.01% |
23,547
-89,312
| -79% | -$3.87M |
|
|
AV
2620
DELISTED
Aviva Plc
AV
| $1.09M | ﹤0.01% |
70,026
+20,030
| +40% | +$326K |
|
2621
Tennant Co
TNC
$1.48B
| $1.09M | ﹤0.01% |
+16,673
| New | +$1.09M |
|
2622
Hovnanian Enterprises
HOV
$782M
| $1.09M | ﹤0.01% |
16,356
-11,466
| -41% | -$903K |
|
2623
Matrix Service
MTRX
$347M
| $1.09M | ﹤0.01% |
59,520
+21,783
| +58% | +$427K |
|
|
IPHI
2624
DELISTED
INPHI CORPORATION
IPHI
| $1.09M | ﹤0.01% |
47,609
-38,435
| -45% | -$854K |
|
2625
TherapeuticsMD
TXMD
$24M
| $1.09M | ﹤0.01% |
2,764
+2,214
| +403% | +$781K |
|
Similar funds
D.E. Shaw & Co's Q2 2015 Portfolio in Review
As of Q2 2015, D.E. Shaw & Co held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co's Q2 2015 filing shows 504 new, 1,541 increased, 1,228 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Healthcare.
- D.E. Shaw & Co's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- D.E. Shaw & Co added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- D.E. Shaw & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- D.E. Shaw & Co fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- D.E. Shaw & Co opened 504 new positions and closed 364 in Q2 2015.
- D.E. Shaw & Co's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.